Navigation Links
Lixte Biotechnology Holdings Compound LB-205 Reported to Have Therapeutic Potential for Gaucher Disease
Date:12/19/2011

EAST SETAUKET, N.Y., Dec. 19, 2011 /PRNewswire/ -- An article in the early edition (December 12, 2011) of the Proceedings of the National Academy of Sciences USA, reported that Lixte's investigational drug, LB-205, was shown to have therapeutic potential in a laboratory model of Gaucher disease  (http://www.pnas.org/content/early/2011/12/08/1119181109.full.pdf+html).

John Kovach, MD, founder and president of Lixte said, "This is a novel use of the class of drugs known as histone deacetylase inhibitors (HDACi's). HDACi's have been used clinically primarily as an anticancer treatments. To our knowledge, this is the first time HDACi's have been shown to have therapeutic potential in a model of Gaucher disease. We were pleased that the effectiveness of LB-205 compared favorably with a clinically approved HDACi.  Primary treatment for many Gaucher disease patients is injection of the enzyme, glucocerebrosidase, which decreases the toxic accumulation of glucocerebroside in many tissues. Unfortunately, in some patients, the brain is significantly affected by glucocerebroside accumulation and the injected enzyme does enter the brain readily. Although the effectiveness of HDACi's for Gaucher treatment remains to be proven in clinical studies, the discovery is intriguing because some HDACi's, like LB-205, penetrate the brain and may be effective given by mouth rather than injection, simplifying long term management."

About Lixte Biotechnology Holdings, Inc.
Lixte is a cancer drug discovery company, using biomarker technology and innovative chemistry to develop new potentially more effective anti-cancer drugs. It has lead compounds in two classes of drugs, protein phosphatase inhibitors for which a US patent was recently issued with world-wide patent applications pending for a lead compound LB-100 and structural variants , and novel histon
'/>"/>

SOURCE Lixte Biotechnology Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
2. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
3. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
4. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
5. Lixte Biotechnology Holdings, Inc. Announces the Approval of a Collaboration with the National Cancer Institute for Clinical Evaluation of its Lead Anti-Cancer Compound, LB-100.
6. Lixte Biotechnology Holdings, Inc. Awarded Grant Under Qualifying Therapeutic Discovery Project from the U. S. Government
7. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
8. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
9. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
10. Genetic Engineering & Biotechnology News Reports on the Growing Role of Ion-Channel Studies in Global Biotech R&D
11. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014 Reportlinker.com announces ... is available in its catalogue: ... and Approval of Imported Medical Device ... Edition) http://www.reportlinker.com/p02342770/-Latest-Chinese-Guidebook-for-Application-and-Approval-of-Imported-Medical-Device-Registration-From-Regulations-to-Practices--2014-Edition ... Chinese regulations on medical devices are ...
(Date:8/27/2014)... LYNDHURST N.J. and NINGBO, China ... ("Amerigen") and the Ningbo Menovo Pharmaceutical Co., Ltd, ("Menovo") ... regarding the development of generic pharmaceuticals, primarily targeting ... terms of the agreement, Amerigen and Menovo will jointly ... the United States . Menovo will be responsible ...
(Date:8/27/2014)... , Aug. 27, 2014 /PRNewswire-iReach/ -- ... system design, blended emergency medical training and response ... external defibrillator) training from the Department of ... Army Reserve 81 st Regional Support Command ... Investigations contract includes nationwide CPR/AED/First Aid training. The ...
Breaking Medicine Technology:Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 2Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 3Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 4Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 5Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 6Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 7Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 8Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 9Latest Chinese Guidebook for Application and Approval of Imported Medical Device Registration: From Regulations to Practices (2014 Edition) 10Amerigen Pharmaceuticals Limited and the Ningbo Menovo Pharmaceutical Co., Ltd, today announced they had entered into a collaboration agreement regarding the development of generic pharmaceuticals, primarily targeting the United States market 2Emergency University Equips Homeland Security, Army Reserve with SCA Response Program to Save Lives of Sudden Cardiac Arrest Victims 2Emergency University Equips Homeland Security, Army Reserve with SCA Response Program to Save Lives of Sudden Cardiac Arrest Victims 3
... ITelagen, Inc., a leading provider of healthcare IT and ... to the prestigious 2011 Inc. 5000 list, a compendium of ... This was the second year in a row that ... the list at position #2093, with an extraordinary four-year growth ...
... 23, 2011 /PRNewswire-Asia/ -- WuXi AppTec announced today ... a certificate of Good Laboratory Practice (GLP) from ... and the European Union (EU).   ... Shanghai is able to carry out ADME (absorption, ...
Cached Medicine Technology:ITelagen Named to Prestigious 2011 Inc. 5000 List of Fastest-Growing Companies 2WuXi AppTec Bioanalytical Services Unit Receives GLP Certificate from OECD and EU 2
(Date:8/27/2014)... (PRWEB) August 27, 2014 Shawna's new ... 2014, is about Seed Digging, which a brand-new technique ... therapy models, yet works to bring permanent healing quickly. ... addictions and mental health disorders cured on a daily ... their own minds and find incredible inner peace with ...
(Date:8/27/2014)... 28, 2014 Recently, iFitDress.com, a professional ... its new designs of romantic bridal gowns . ... a promotional price (up to 66 percent off) when ... company’s product line has been updated with these new ... patient. iFitDress.com hopes that all clients can gain an ...
(Date:8/27/2014)... Calif. (PRWEB) August 27, 2014 Seventy-three ... of Pharmacy (SoP) celebrated the beginning of their careers ... on Saturday, August 23. Students entering a four-year PharmD ... and care ?to welcome them into the profession as ... the ceremony held at the Garrison Theater in Claremont, ...
(Date:8/27/2014)... Santa Clara, CA (PRWEB) August 27, 2014 ... Mexico vs. Chile tickets at Levi’s Stadium in ... facility located in Santa Clara, California just opened in July ... September 6 when Mexico takes on Chile. These are two ... performances at the 2014 World Cup and will look to ...
(Date:8/27/2014)... 2014 Dr. Stewart Shofner ... multitudes of patients suffering from impaired vision. Some of ... vision correction surgery . Recently, Dr. Shofner has noticed ... an eye exam and also online. To help patients ... myths about glaucoma. , 1)    Myth: People with perfect vision ...
Breaking Medicine News(10 mins):Health News:Shawna Burns, Counselor, Releases Debut Book, "Seed Digging," to Improve Lives of Children and Adults with Addictions and Mental Health Disorders 2Health News:Promotion For Romantic Bridal Gowns Launched By Professional Company iFitDress.com 2Health News:Founding Class of the KGI School of Pharmacy Formally Welcomed into the Profession at a Traditional White Coat Ceremony 2Health News:Mexico vs. Chile Tickets at Levi’s Stadium: Ticket Down Cuts Ticket Prices for Inaugural Soccer Match between Chile and Mexico in Santa Clara 2Health News:Mexico vs. Chile Tickets at Levi’s Stadium: Ticket Down Cuts Ticket Prices for Inaugural Soccer Match between Chile and Mexico in Santa Clara 3Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 3Health News:Renowned Eye Surgeon Dr. Stewart Shofner Debunks Top Five Myths About Glaucoma 4
... The extent of heart muscle damage in heart attack patients ... -- the body,s main artery from the heart -- before ... angioplasty, a new study finds. The balloon pump, or ... to the heart in order to reduce its workload. Animal ...
... 30 (HealthDay News) -- Intense competition, not violence, may ... aggression, according to a small new study. It ... games such as "Fuel," "Mortal Kombat" and "Left 4 ... and violence. The participants, levels of aggression were assessed ...
... cohort study provide robust evidence of an "important" ... The reduction in incidence was found when a ... early generation drug-eluting stents (DES) at long-term follow-up. ... observed between one and four years after implantation ...
... Jenifer Goodwin HealthDay Reporter , MONDAY, Aug. ... temptation are more likely than patient preschoolers to grow ... "What we,re seeing is that there are some ... lead study author B.J. Casey, a cognitive neuroscientist at ...
... News) -- ,Having a secure attachment with their mother helps ... new study finds. It included 84 infants who were ... a month of birth and was based on the infants, ... hearing a bell ringing. About one third of the infants ...
... from a study presented today at the ESC Congress 2011, show ... procedural success (versus 95.3% in the high Euroscore group (p=0.1). ... of death at one month in the low Euroscore group, versus ... (p Aortic stenosis is the most frequently acquired valve ...
Cached Medicine News:Health News:Heart Attack Damage Not Reduced by Adding Balloon Pump to Angioplasty 2Health News:An 'important' reduction in risk of stent thrombosis with everolimus-eluting stent 2Health News:'Gimme' Kids Often Grow Into 'Gimme' Adults 2Health News:'Gimme' Kids Often Grow Into 'Gimme' Adults 3Health News:Transcatheter aortic valve implantation with the Edwards valve prosthesis in patients with low 2
... The BariMaxx™ is a full-featured healthcare ... environment for the care and management of ... up to 1000 lbs. ,Large patients at ... weight in excess of 1000 lbs. (including ...
... folding head end and foot end deck panels for ... and foot end deck panels folded the overall length ... compact length makes storage, delivery and pick up a ... available on Model 4748B, Basic Maxi Rest bariatric bed, ...
... Caregiver safety. Patient dignity. A single ... Bariatric Bed to provide added safety where ... is engineered to help protect the caregiver ... efficiency. The bed functions just like other ...
... 28%-100% FIO 2 1000ML 0.45% Sodium Chloride ... nebulizers provide unmatched performance and ease of use. ... adjustable from 28% to 100% FIO 2 . ... water for inhalation, USP; 0.45% sodium chloride inhalation, ...
Medicine Products: